|
12 January, 2022
|
ICON Issues Financial Guidance for Full Year 2022
|
|
|
05 January, 2022
|
ICON plc to Present at the 40th Annual JP Morgan Healthcare Conference
|
|
|
07 December, 2021
|
ICON Named Best Contract Research Organisation in Latest String of Industry Awards
|
|
|
22 November, 2021
|
ICON Releases Environmental, Social and Governance Report
|
|
|
10 November, 2021
|
ICON Announces the Expansion of its Accellacare Site Network
|
|
|
05 November, 2021
|
ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference
|
|
|
03 November, 2021
|
ICON Reports Third Quarter 2021 Results
|
|
|
22 September, 2021
|
Tánaiste announces multi-million Euro R&D support of ICON to accelerate decentralised clinical trial technology
|
|
|
02 September, 2021
|
ICON plc to Present at the Wells Fargo 16th Annual Healthcare Conference and the Baird Global Healthcare Conference
|
|
|
21 July, 2021
|
ICON Reports Second Quarter 2021 Results
|
|
|
21 July, 2021
|
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
|
|
|
01 July, 2021
|
ICON acquisition creates world-leading healthcare intelligence and clinical research organisation
|
|
|
17 June, 2021
|
ICON Announces Pricing of Senior Secured Notes
|
|
|
15 June, 2021
|
ICON Shareholders Vote in Favour of All Resolutions at its Extraordinary General Meeting
|
|
|
14 June, 2021
|
ICON Announces Private Offering of Senior Secured Notes
|
|
|
25 May, 2021
|
ICON plc to Present at the Jefferies Virtual Healthcare Conference and the William Blair 41st Growth Stock Conference
|
|
|
05 May, 2021
|
ICON plc to Present at the BofA Securities 2021 Virtual Healthcare Conference and the UBS Virtual Global Healthcare Conference
|
|
|
28 April, 2021
|
ICON Reports First Quarter 2021 Results
|
|
|
20 April, 2021
|
ICON wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a row
|
|
|
09 March, 2021
|
ICON plc to Present at the Barclays Global Healthcare Conference and the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
|
|
